In the current study, we sought to determine the regulatory mechanism of miR‐378a‐3p‐containing MSCs‐EVs in IBD and identified that it could inhibit the progression of IBD by blockade of the AQP4/GATA2/PPAR‐α axis. This evidence concerns the gene GATA2 and inflammatory bowel disease.